week 1: indications

alendronate sodium

• treatment of osteoporosis in postmenopausal women

• prevention of osteoporosis in postmenopausal women

• increase bone mass in men with osteoporosis

• treatment of glucocorticoid-induced osteoporosis in men and women

• treatment of Paget’s disease

amoxicillin trihydrate

• infections due to susceptible strains of the following gram-negative organisms: H. influenzae, E. coli, P. mirabilis, and N. gonorrhoeae

• gonorrhea and acute uncomplicated urethral and anogenital infections due to N. gonorrhea

amoxicillin with clavulanate potassium

• sinusitis and otitis media due to beta-lactamase producing strains of H. influenzae and B. catarrhalis; lower respiratory tract infections due to beta-lactamase producing strains of H. influenzae, skin and skin structure infections due to beta-lactamase producing strains of Staphylococcus aureus, E. coli, and Klebsiella species, and urinary tract infections due to beta-lactamase producing strains of E. coli, Klebsiella species and Enterobacter species

• recurrent acute otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis characterized by antiobiotic exposure for AOM within the prior 3 months and either age ≤2 years or day care attendance

• acute bacterial sinusitis or community acquired pneumonia due to confirmed beta-lactamase producing strains of susceptible bacteria

azithromycin dihydrate

cefdinir

cephalexin monohydrate

ciprofloxacin hydrochloride

clindamycin hydrochloride

doxycycline hyclate

levofloxacin

minocycline hydrochloride

mupirocin

ofloxacin

raloxifene hydrochloride

sulfamethoxazole with trimethoprim